Immuneering-logo (1).png
Immuneering Announces Participation in February Investor Conferences
February 01, 2024 08:00 ET | Immuneering Corporation
CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop universal-RAS/RAF medicines for broad populations of...
enteralogo.png
Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 30, 2024 08:30 ET | Entera Bio Ltd.
JERUSALEM, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced...
Ion Beam Facility: Then
APTIM Selected by U.S. Department of Energy to Decommission Ion Beam Facility
August 15, 2023 08:00 ET | APTIM
Baton Rouge, La., Aug. 15, 2023 (GLOBE NEWSWIRE) -- The U.S. Department of Energy (DOE) has selected APTIM to deactivate, decommission, and remove (DD&R) the Ion Beam Facility (IBF), a former...
Oppenheimer headshot from Newsreel clip_HearstNews_UCLA_2
Historic Newsreel Clip: Oppenheimer Issues Warning
July 21, 2023 22:45 ET | UCLA Film & Television Archive
Los Angeles, CA, July 21, 2023 (GLOBE NEWSWIRE) -- Clip from Oct. 26, 1945; 50 seconds: ATOM BOMB SCIENTIST WARNS AMERICA OF DANGERS AHEAD! Research chief of atomic project, Dr. J. Robert...
CreativeMammals_Logo.jpg
Creative Mammals Revealed as Animation Studio Behind NBC News Studios' ‘To End All War: Oppenheimer & The Atomic Bomb’
July 07, 2023 10:00 ET | Creative Mammals
Film airs July 9th at 10pm ET on MSNBC; streaming on Peacock Watch the official trailer here ATLANTA, July 07, 2023 (GLOBE NEWSWIRE) -- Creative Mammals is proud to announce its first...
HRBlock_Logo.jpg
H&R Block to Participate in the Oppenheimer 23rd Annual Consumer Growth & E-Commerce Conference
May 30, 2023 16:35 ET | HRB Tax Group, Inc.
KANSAS CITY, Mo., May 30, 2023 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) (the “Company”) today announced that Jeff Jones, President and Chief Executive Officer, and Tony Bowen, Chief...
2019 logo_150x35_jpg.jpg
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 14, 2023 08:30 ET | Novan, Inc.
DURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...
Synlogic_Logo_Blue.png
Synlogic to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 08, 2023 07:00 ET | Synlogic, Inc.
CAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B....
logo.jpg
Processa Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023 08:30 ET | Processa Pharmaceuticals, Inc.
HANOVER, MD, March 07, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), the developer of the Next Generation Chemotherapy drugs that will provide...
fortressbio1.jpg
Fortress Biotech to Participate in Two March 2023 Investor Conferences
March 07, 2023 08:00 ET | Fortress Biotech, Inc.
MIAMI, March 07, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing...